ELIZABETH DECK: Open Payments
NPI 1396715546 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 35 payments from 16 companies in 2025. Trend: 2023 $347 · 2024 $796 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $168 |
| ABBVIE INC. | 5 | $112 |
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| Corcept Therapeutics | 2 | $48 |
| Lilly USA, LLC | 2 | $48 |
| Dexcom, Inc. | 1 | $42 |
| PFIZER INC. | 2 | $40 |
| Exact Sciences Corporation | 2 | $40 |
| JAZZ PHARMACEUTICALS INC. | 1 | $40 |
| Amgen Inc. | 1 | $26 |
Products named: Wegovy, FARXIGA, VRAYLAR, Korlym, MOUNJARO, Ozempic, Dexcom G6 Transmitter, Cologuard Collection Kit.
Industry payments across IL — which companies pay providers there.
